<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00553995</url>
  </required_header>
  <id_info>
    <org_study_id>H-23068</org_study_id>
    <nct_id>NCT00553995</nct_id>
  </id_info>
  <brief_title>Effect of Salsalate on Bed Rest-Induced Vascular Dysfunction</brief_title>
  <official_title>Effect of Physical Inactivity on Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physical inactivity induces vascular dysfunction and glucose intolerance during five days of&#xD;
      bed rest. This study will investigate the effects of salsalate on these responses. Subjects&#xD;
      will be randomized to treatment with salsalate or placebo for four days prior to initiation&#xD;
      of bed rest. Vascular function in the brachial artery will be determined by ultrasound prior&#xD;
      to treatment and before and after the 5-day bed rest protocol. We hypothesize that treatment&#xD;
      with salsalate will be associated with protection again the development of glucose&#xD;
      intolerance and vascular dysfunction in this setting.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2008</start_date>
  <completion_date type="Actual">December 1, 2014</completion_date>
  <primary_completion_date type="Actual">December 1, 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reactive hyperemia in the femoral artery</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reactive hyperemia in the brachial artery</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral glucose tolerance test</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Salsalate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Salsalate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>salsalate</intervention_name>
    <description>Salsalate 3-4 grams per day as tolerated for nine days</description>
    <arm_group_label>Salsalate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of Coronary Artery Disease&#xD;
&#xD;
          -  Diabetes Mellitus&#xD;
&#xD;
          -  Hypertension&#xD;
&#xD;
          -  Cigarette smoking&#xD;
&#xD;
          -  History or family history of deep vein thrombosis or pulmonary embolism&#xD;
&#xD;
          -  Abnormal renal function&#xD;
&#xD;
          -  Liver function tests greater than two times the upper limit of normal&#xD;
&#xD;
          -  Anemia&#xD;
&#xD;
          -  Use of viagra or other PDE5 inhibitor&#xD;
&#xD;
          -  Hypercholesterolemia&#xD;
&#xD;
          -  Aspirin allergy/sensitivity&#xD;
&#xD;
          -  Asthma with nasal polyps&#xD;
&#xD;
          -  Peptic ulcer disease/Gastrointestinal bleeding&#xD;
&#xD;
          -  Any ongoing drug treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naomi Hamburg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston University School of Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>November 5, 2007</study_first_submitted>
  <study_first_submitted_qc>November 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2007</study_first_posted>
  <last_update_submitted>March 8, 2017</last_update_submitted>
  <last_update_submitted_qc>March 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University</investigator_affiliation>
    <investigator_full_name>Naomi M Hamburg</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salicylsalicylic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

